Skip to main content

Table 2 Antimicrobial susceptibility patterns of 58 Aeromonads separated from bacteremia

From: Taxonomy, virulence determinants and antimicrobial susceptibility of Aeromonas spp. isolated from bacteremia in southeastern China

Antimicrobial agent CLSI breakpoint interpretation (%) MIC50 MIC range
S I R
Ceftazidime 88 1.7 10.3  ≤ 1  ≤ 1 ~  ≥ 64
Cefotetan 86.2 0 13.8  ≤ 4  ≤ 4 ~  ≥ 64
Ceftriaxone 79.3 5.2 15.5  ≤ 1  ≤ 1 ~  ≥ 64
Cefepime 98.3 0 1.7  ≤ 1  ≤ 1 ~ 32
Piperacillin/tazobactam 88 1.7 10.3  ≤ 4  ≤ 4 ~  ≥ 128
Aztreonam 91.4 3.4 5.2  ≤ 1  ≤ 1 ~  ≥ 64
Imipenem 75.9 10.3 13.8  ≤ 1  ≤ 1 ~  ≥ 16
Levofloxacin 96.6 1.7 1.7  ≤ 0.25  ≤ 0.25 ~  ≥ 8
Ciprofloxacin 96.6 0 3.4  ≤ 0.25  ≤ 0.25 ~  ≥ 4
TRIMETHOPRIM/sulfamethoxazole 87.9 0 12.1  ≤ 20  ≤ 20 ~  ≥ 320
Amikacin 100 0 0  ≤ 2  ≤ 2
Gentamicin 100 0 0  ≤ 1  ≤ 1
Tobramycin 93.1 5.2 1.7  ≤ 1  ≤ 1 ~  ≥ 16
Furantoin 100 0 0  ≤ 16  ≤ 16